Clinical Trials Browser

Withdrawn × Interferon-alpha × Dermatologic × Clear all

NCT00447356 2013-05-13

High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

Phase 3 Withdrawn

Melanoma